<DOC>
	<DOCNO>NCT02930434</DOCNO>
	<brief_summary>The purpose study evaluate vitamin D ( VD ) deficiency population Chilean Antarctica evaluate efficacy safety VD supplementation decrease VD deficiency favorably influence biomarkers bone , cardiovascular , immune health risk inhabitant Chilean Antarctica .</brief_summary>
	<brief_title>Effects Antarctic Environment Vitamin D Status Health Risk Biomarkers Its Inhabitants</brief_title>
	<detailed_description>The present study consist initial cross-sectional evaluation VD status specific health biomarkers inhabitant Chilean Antarctica , follow randomize control trial evaluate two acceptable approach vitamin D supplementation ( cholecalciferol 600 IU daily vs. 25000 IU weekly ) Antarctic inhabitant .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>population age live Chilean Antarctic territory least 3 month . acute chronic renal disease hyper hypocalcemia osteomalacia Paget 's disease bone use VD supplement fish oil supplement past month dose high 400 IU daily treatment know VD deficiency last 6 month UV phototherapy past month .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>Antarctica</keyword>
	<keyword>Chile</keyword>
	<keyword>cathelicidin</keyword>
	<keyword>bone metabolism</keyword>
	<keyword>cardiovascular risk</keyword>
</DOC>